Blood Donors

• 

  Subject Areas on Research

  • Access, entanglement, and prosociality. 
  • Alternate analysis strategies for retrospective assessment of outcomes with a male donor-only plasma policy. 
  • Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors. 
  • Apheresis for collection of Ebola convalescent plasma in Liberia. 
  • Autologous blood procurement in the surgical setting: lessons learned in the last 10 years. 
  • Autologous blood use for free flap breast reconstruction: a comparative evaluation of a preoperative blood donation program. 
  • Blood banks, biobanks, and the ethics of donation. 
  • Carboxyhemoglobin levels in banked blood. 
  • Carboxyhemoglobinemia in a pediatric cardiopulmonary bypass patient derived from a contaminated unit of allogenic blood. 
  • Chagas Disease Screening in Maternal Donors of Publicly Banked Umbilical Cord Blood, United States. 
  • Changes in protein-bound, complex-bound, and ionized calcium related to parathyroid hormone levels in healthy donors during plateletapheresis. 
  • Characterization of human anti-porcine "natural antibodies" recovered from ex vivo perfused hearts--predominance of IgM and IgG2. 
  • Combination immunotherapy with clinical-scale enriched human gammadelta T cells, hu14.18 antibody, and the immunocytokine Fc-IL7 in disseminated neuroblastoma. 
  • Comparison of cardiac marker concentrations in healthy blood donors and hospital patients without acute coronary syndrome. 
  • Cord-blood transplants from unrelated donors in Hurler's syndrome. 
  • Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. 
  • Detection of platelet isoantibodies by (3H)serotonin platelet release and its clinical application to the problem of platelet matching. 
  • Donor leukocyte infusions in recurrent Hodgkin lymphoma following allogeneic stem cell transplant: 10-year experience at the M. D. Anderson Cancer Center. 
  • Drug resistance and HCV coinfection in former blood donors infected with HIV type 1 in China. 
  • Effectiveness of preoperative autologous blood donation for protection against allogeneic blood exposure in adult spinal deformity surgeries: a propensity-matched cohort analysis. 
  • Emerging infectious diseases: new and resistant strains of HIV. 
  • Ethical issues in umbilical cord blood banking. Working Group on Ethical Issues in Umbilical Cord Blood Banking. 
  • Evaluation of the Abbott m2000rt RealTime HIV-1 assay with manual sample preparation compared with the ROCHE COBAS AmpliPrep/AMPLICOR HIV-1 MONITOR v1.5 using specimens from East Africa. 
  • Foundation for the Accreditation of Hematopoietic Cell Therapy (FAHCT) response to FDA (Docket no. 97N-0068). FAHCT Board of Directors. 
  • Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. 
  • Human gammadelta T cells from G-CSF-mobilized donors retain strong tumoricidal activity and produce immunomodulatory cytokines after clinical-scale isolation. 
  • In reply. 
  • In vivo and in vitro characteristics of double units of RBCs collected by apheresis with a single in-line WBC-reduction filter. 
  • Incidence of Herpesvirus hominis antibodies among blood donor populations. 
  • Large-scale mobilization and isolation of CD34+ cells from normal donors. 
  • Long antibody HCDR3s from HIV-naïve donors presented on a PG9 neutralizing antibody background mediate HIV neutralization. 
  • Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients. 
  • Many, but not all, outcome studies support exclusion of female plasma from the blood supply. 
  • No association between donor age and recipient outcomes: transfusion of plasma in patients undergoing coronary artery bypass grafting surgery. 
  • Optimization of informed consent for umbilical cord blood banking. 
  • Optimizing donor selection for public cord blood banking: influence of maternal, infant, and collection characteristics on cord blood unit quality. 
  • Pediatric large-volume leukapheresis: a single institution experience with heparin versus citrate-based anticoagulant regimens. 
  • Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. 
  • Platelet factor 4/heparin antibodies in blood bank donors. 
  • Prevalence of HTLV-I-associated T-cell lymphoma. 
  • Profiles of neutralizing antibody response in chronically human immunodeficiency virus type 1 clade B'-infected former plasma donors from China naive to antiretroviral therapy. 
  • Public attitudes to the storage of blood left over from routine general practice tests and its use in research. 
  • Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood. 
  • Rapid freezing of whole blood or buffy coat samples for polymerase chain reaction and cell culture analysis: application to detection of human immunodeficiency virus in blood donor and recipient repositories. The Transfusion Safety Study Group. 
  • Red cell transfusion in the newborn. Indications and unique blood banking needs. 
  • Responding to the immunoglobulin shortage: a case study. 
  • Results of the cord blood transplantation (COBLT) study unrelated donor banking program. 
  • Risk-based decision making and ethical considerations in donor compensation for plasma-derived medicinal products. 
  • Smoking and disease: effect on serum antitrypsin in hospitalized patients. 
  • Stress and coping in HIV-positive former plasma/blood donors in China: a test of cognitive appraisal theory. 
  • The Cord Blood Apgar: a novel scoring system to optimize selection of banked cord blood grafts for transplantation (CME). 
  • The contribution of sociodemographic, medical, and attitudinal factors to blood donation among the general public. 
  • Transfusion medicine: the problem of HIV infection. 
  • Transfusion of sickle cells may be a therapeutic option for patients suffering metastatic disease. 
  • Transplant outcomes in mucopolysaccharidoses. 
  • Umbilical cord blood donation: public or private? 
  • Understanding disparities in donor behavior: race and gender differences in willingness to donate blood and cadaveric organs. 
  • Untying the Gordian knot: policies, practices, and ethical issues related to banking of umbilical cord blood. 
  • Variability in generation of anti-sheep erythrocyte plaque-forming cells from cultures of human peripheral blood. Influence of monocytes. 
• 

  Keywords of People

  • Barfield, Raymond Carlton, Professor of Pediatrics, Duke Science & Society